Zureikat Amer H, Nguyen Kevin T, Bartlett David L, Zeh Herbert J, Moser A James
Division of Surgical Oncology, University of Pittsburgh Medical Center Pancreatic Cancer Center, 3550 Terrace St., Pittsburgh, PA 15261, USA.
Arch Surg. 2011 Mar;146(3):256-61. doi: 10.1001/archsurg.2010.246. Epub 2010 Nov 15.
Robotic-assisted pancreatic resection and reconstruction are safe and can reproduce perioperative results seen in open surgery.
Single-institution retrospective review.
Tertiary care center.
Patients undergoing completed robotic-assisted pancreatic resection and reconstruction at the University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, between October 3, 2008, and February 26, 2010.
Primary pathology, operative time, operative blood loss, perioperative blood transfusions, pancreatic fistula, 90-day morbidity and mortality, and readmission rate.
Thirty patients with a median age of 70 years (range, 32-85 years) underwent completed robotic-assisted pancreatic resection and reconstruction. Procedures were robotic-assisted non-pylorus-preserving pancreaticoduodenectomy (n = 24), robotic-assisted central pancreatectomy (n = 4), and the robotic-assisted Frey procedure (n = 2). The median operative time was 512 minutes (range, 327-848 minutes). The median blood loss was 320 mL (range, 50-1000 mL), with a median length of hospital stay of 9 days (range, 4-87 days). The final diagnoses included periampullary adenocarcinoma (n = 7), pancreatic ductal adenocarcinoma (n = 6), pancreatic neuroendocrine tumor (n = 5), intraductal papillary mucinous neoplasm (n = 4), mucinous cystic neoplasm (n = 3), serous cystic adenoma (n = 2), chronic pancreatitis (n = 2), and solid pseudopapillary neoplasm (n = 1). There was 1 postoperative death. The overall pancreatic fistula rate was 27% (n = 8). The clinically significant pancreatic fistula rate (International Study Group on Pancreatic Fistula grades B and C) was 10% (n = 3). Clavien grade III and IV complications occurred in 7 patients (23%), while Clavien grade I and II complications occurred in 8 patients (27%).
Robotic-assisted complex pancreatic surgery can be performed safely in a high-volume pancreatic tertiary care center with perioperative outcomes comparable to those of open surgery. Advances in robotic technology and increasing experience may improve long operative times.
机器人辅助胰腺切除与重建手术是安全的,并且能够重现开放手术的围手术期结果。
单机构回顾性研究。
三级医疗中心。
2008年10月3日至2010年2月26日期间,在宾夕法尼亚州匹兹堡市匹兹堡大学医学中心接受完整机器人辅助胰腺切除与重建手术的患者。
主要病理学检查结果、手术时间、术中失血量、围手术期输血情况、胰瘘、90天发病率和死亡率以及再入院率。
30例患者接受了完整的机器人辅助胰腺切除与重建手术,中位年龄为70岁(范围32 - 85岁)。手术包括机器人辅助非保留幽门胰十二指肠切除术(n = 24)、机器人辅助中央胰腺切除术(n = 4)和机器人辅助Frey手术(n = 2)。中位手术时间为512分钟(范围327 - 848分钟)。中位失血量为320毫升(范围50 - 1000毫升),中位住院时间为9天(范围4 - 87天)。最终诊断包括壶腹周围腺癌(n = 7)、胰腺导管腺癌(n = 6)、胰腺神经内分泌肿瘤(n = 5)、导管内乳头状黏液性肿瘤(n = 4)、黏液性囊性肿瘤(n = 3)、浆液性囊性腺瘤(n = 2)、慢性胰腺炎(n = 2)和实性假乳头状肿瘤(n = 1)。术后有1例死亡。总体胰瘘发生率为27%(n = 8)。具有临床意义的胰瘘发生率(国际胰瘘研究组B级和C级)为10%(n = 3)。7例患者(23%)发生Clavien III级和IV级并发症,8例患者(27%)发生Clavien I级和II级并发症。
在大型胰腺三级医疗中心,机器人辅助复杂胰腺手术可安全进行,围手术期结果与开放手术相当。机器人技术的进步和经验的增加可能会改善较长的手术时间。